Geneos Wealth Management’s CSX Corp CSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.5M Sell
157,786
-1,923
-1% -$86.8K 0.15% 153
2026
Q1
$6.56M Buy
159,709
+1,003
+0.6% +$39.3K 0.15% 158
2025
Q4
$5.75M Sell
158,706
-1,069
-0.7% -$38.3K 0.14% 184
2025
Q3
$5.67M Sell
159,775
-8,209
-5% -$280K 0.14% 180
2025
Q2
$5.48M Sell
167,984
-73,483
-30% -$2.21M 0.13% 188
2025
Q1
$7.11M Buy
241,467
+169,559
+236% +$5.39M 0.1% 247
2024
Q4
$2.32M Sell
71,908
-144
-0.2% -$4.94K 0.08% 270
2024
Q3
$2.49M Buy
72,052
+11,696
+19% +$397K 0.09% 250
2024
Q2
$2.02M Sell
60,356
-1,251
-2% -$42.5K 0.09% 247
2024
Q1
$2.28M Buy
61,607
+112
+0.2% +$4.09K 0.1% 227
2023
Q4
$2.13M Sell
61,495
-150
-0.2% -$4.78K 0.11% 221
2023
Q3
$1.9M Sell
61,645
-1,000
-2% -$31.7K 0.1% 220
2023
Q2
$2.14M Buy
62,645
+9
+0% +$285 0.11% 207
2023
Q1
$1.88M Sell
62,636
-104
-0.2% -$3.2K 0.11% 208
2022
Q4
$1.94M Sell
62,740
-2,220
-3% -$66.8K 0.12% 182
2022
Q3
$1.73M Sell
64,960
-21,284
-25% -$662K 0.12% 179
2022
Q2
$2.53M Buy
86,244
+413
+0.5% +$13.5K 0.13% 182
2022
Q1
$3.21M Buy
85,831
+547
+0.6% +$19.3K 0.14% 166
2021
Q4
$3.21M Sell
85,284
-4,740
-5% -$167K 0.12% 178
2021
Q3
$2.73M Buy
90,024
+963
+1% +$30.8K 0.1% 202
2021
Q2
$2.9M Sell
89,061
-14,136
-14% -$466K 0.11% 194
2021
Q1
$3.46M Sell
103,197
-14,316
-12% -$437K 0.1% 216
2020
Q4
$3.83M Sell
117,513
-3,147
-3% -$90.4K 0.15% 152
2020
Q3
$3.14M Buy
120,660
+87
+0.1% +$2.15K 0.16% 145
2020
Q2
$2.65M Buy
120,573
+534
+0.4% +$11.8K 0.15% 150
2020
Q1
$2.25M Buy
120,039
+11,382
+10% +$266K 0.15% 151
2019
Q4
$2.64M Buy
108,657
+1,425
+1% +$33.7K 0.14% 170
2019
Q3
$2.46M Buy
107,232
+12,054
+13% +$281K 0.15% 160
2019
Q2
$2.45M Buy
95,178
+237
+0.2% +$6.11K 0.15% 156
2019
Q1
$2.37M Buy
94,941
+324
+0.3% +$7.5K 0.16% 165
2018
Q4
$1.96M Sell
94,617
-129
-0.1% -$2.97K 0.14% 167
2018
Q3
$2.34M Buy
94,746
+1,005
+1% +$23.9K 0.16% 158
2018
Q2
$1.99M Sell
93,741
-1,362
-1% -$28K 0.16% 145
2018
Q1
$1.77M Sell
95,103
-2,613
-3% -$48.8K 0.15% 139
2017
Q4
$1.79M Sell
97,716
-816
-0.8% -$14.4K 0.16% 144
2017
Q3
$1.78M Sell
98,532
-4,938
-5% -$84.8K 0.18% 137
2017
Q2
$1.88M Sell
103,470
-34,077
-25% -$584K 0.19% 122
2017
Q1
$2.13M Sell
137,547
-4,095
-3% -$62.4K 0.22% 108
2016
Q4
$1.7M Sell
141,642
-6,222
-4% -$69.8K 0.22% 109
2016
Q3
$1.5M Buy
147,864
+2,172
+1% +$20.5K 0.2% 120
2016
Q2
$1.27M Sell
145,692
-1,917
-1% -$16.7K 0.18% 122
2016
Q1
$1.26M Buy
+147,609
New +$1.2M 0.19% 122

Other funds holding CSX

Geneos Wealth Management's CSX Position: Q2 2026 in Review

Geneos Wealth Management reduced its CSX Corp (CSX) stake by 1.2% in Q2 2026, selling an estimated $86.8K and leaving 157,786 shares worth $7.5M. The position accounts for 0.15% of the portfolio, ranked #153.

Geneos Wealth Management first reported a position in CSX in Q1 2016 and has held it in 42 quarters since. 1,989 funds tracked by Wall St. Rank hold CSX as of Q2 2026.

  • Geneos Wealth Management held 157,786 shares of CSX Corp worth $7.5M as of Q2 2026.
  • Geneos Wealth Management sold 1,923 CSX Corp shares in Q2 2026, an estimated $86.8K.
  • CSX Corp made up 0.15% of Geneos Wealth Management's portfolio in Q2 2026, its #153 holding.
  • Geneos Wealth Management first reported a position in CSX Corp in Q1 2016 and has held it in 42 quarters since.
  • 1,989 funds tracked by Wall St. Rank held CSX Corp as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.